Please provide your email address to receive an email when new articles are posted on . The addition of lomustine to bevacizumab failed to confer a survival advantage for the treatment of progressive ...

Review the side-effects of Lomustine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Lomustine is a chemotherapy agent with five decades of use in treating lymphomas and central nervous system tumors such as glioblastoma, an aggressive and incurable brain cancer. Despite being an ...

PALO ALTO, Calif., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Orbus Therapeutics, Inc., a private pharmaceutical company, today announced that the combination of eflornithine and lomustine achieved a ...

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and ...

Reiterative Survival Analyses of Total Therapy 2 for Multiple Myeloma Elucidate Follow-Up Time Dependency of Prognostic Variables and Treatment Arms In order to evaluate the impact of lomustine in a ...

HealthDay News — In patients with progressive glioblastoma, treatment with lomustine plus bevacizumab does not confer a survival advantage over treatment with lomustine alone, according to a study ...

Adding lomustine to the standard combination of idarubicin and cytarabine for the treatment of old patients with acute myeloid leukemia improves complete response rates and overall survival. These ...

Lomustine (Lomustine ) is an alkylating agent, prescribed for certain types of cancer. It stops or slows the growth of cancer cells. The information provided on this page is intended to serve as a ...

Relationship Between Plasma Estradiol Levels and Estrogen-Responsive Gene Expression in Estrogen Receptor–Positive Breast Cancer in Postmenopausal Women Patients were randomly assigned 2:1 to receive ...

Although the success of auto-HSCT depends on several variables, the lower the toxicity and the duration of neutropenia the smaller the treatment-related mortality. Given that lomustine has low ...

Please provide your email address to receive an email when new articles are posted on . Lomustine added to standard induction therapy improved complete remission and survival in patients aged older ...